PMID: 19941277Nov 27, 2009Paper

Treatment of secondary hyperparathyroidism in dialysis patients

Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia
M Di Luca

Abstract

Secondary hyperparathyroidism is an important complication in chronic kidney disease (CKD). It is associated with mineral and bone disorders and with increased cardiovascular morbidity and mortality. Despite standard treatment, adequate control of all biochemical targets for CKD-mineral and bone disorder (CKD-MBD) remains suboptimal and is accomplished only in a minority of patients receiving hemodialysis. New insights into the pathogenesis of secondary hyperparathyroidism and the development of new therapeutic agents are offering new possibilities to improve the treatment of this condition in patients with CKD. This article provides an overview of the current understanding of secondary hyperparathyroidism and evidence supporting strategies for its treatment, which is complex and requires multiple interventions. The ''modern'' treatment of secondary hyperparathyroidism in dialysis patients consists of free-calcium and aluminium phosphate binders, vitamin D receptor activators (VDRAs), and calcimimetics, even though calcium- and aluminum-based phosphate binders and calcitriol are not without complications. Additional data are needed to determine the optimal combination of phosphate binders, VDRAs and calcimimetics, and to establ...Continue Reading

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.